HAE - HAEMONETICS CORP


61.17
-0.450   -0.736%

Share volume: 554,784
Last Updated: 04-20-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$61.62
-0.45
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
40%
Profitability 18%
Dept financing 41%
Liquidity 34%
Performance 63%
Company vs Stock growth
vs
Performance
5 Days
1.76%
1 Month
4.64%
3 Months
-12.75%
6 Months
19.50%
1 Year
7.32%
2 Year
-26.85%
Key data
Stock price
$61.17
P/E Ratio 
21.42
DAY RANGE
$60.57 - $62.15
EPS 
$3.65
52 WEEK RANGE
$47.32 - $87.32
52 WEEK CHANGE
$3.42
MARKET CAP 
3.758 B
YIELD 
N/A
SHARES OUTSTANDING 
46.471 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
1.51
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$610,232
AVERAGE 30 VOLUME 
$640,217
Company detail
CEO: Christopher A. Simon
Region: US
Website: haemonetics.com
Employees: 2,820
IPO year: 1991
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Haemonetics Corporation provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software. It also provides automated blood component and manual whole blood collection systems.

Recent news